Christopher Pelzek, M.D.

80% fewer Medicare Part D claims than the average ophthalmology physician in 2024

307 Medicare Part D claims for 128 beneficiaries, against an average of 1,518 among the 16,459 providers of this specialty who prescribed in Part D. Brand-name drugs were 43% of claims.

Most prescribed

1. Prednisolone Acetate97 claims
2. Tobramycin-Dexamethasone45 claims
3. Dorzolamide-Timolol41 claims
4. Latanoprost31 claims
5. Timolol Maleate21 claims
6. Ketorolac Tromethamine14 claims

Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.

The practice group's Medicare quality score for 2023: 96.2 of 100

The Merit-based Incentive Payment System score is reported for the practice group, not for one clinician alone. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.

Source: CMS Quality Payment Program, MIPS performance year 2023, group reporting; category weights for 2023 (qpp.cms.gov).

Bills Medicare through 2 group practices

1. Retina Associates, PCMerrillville, IN
2. Retina Vitreous Associates, PCOak Lawn, IL

Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov). Star ratings are CMS hospital ratings, not ratings of this provider.